 |  | 

Surviving Against All Odds: Analysis of
6 Case Studies of Patients With Cancer
Who Followed the Gerson Therapy
A. Molassiotis, RN, PhD, and P. Peat, RGN, DiplPallCare
Case 3
This case is a 59-year-old woman (born in 1947) diagnosed
with lobular carcinoma of the right breast in
January 1992 at the age of 45, being node negative
and ER positive. The treatment plan was wide local
excision followed by radiotherapy, the latter commencing
on January 8, 1993.
In May 1995, a surveillance
mammogram showed microcalcification in her
left breast. Needle biopsy showed ductal carcinoma
in situ. It was felt to be extensive, and the treatment
plan was left mastectomy. Evidence of invasive lobular
cancer was found (size/extent not reported).
The
axilla was not operated on at that stage, no radiotherapy
was given, and there was no further adjuvant
chemotherapy or hormonal therapy. In December
1997, she presented with pain in the right axilla and breast changes for the past 2 to 3 months; imaging
and cytology confirmed recurrent tumor within the
right breast together with a palpable node within the
right axilla.
The patient was being planned for a right
mastectomy and level 2 axillary dissection when staging
by CT scan showed evidence of asymptomatic
liver metastases (up to 10), although the lungs and
bones were clear. She was commenced on tamoxifen.
She started the Gerson regimen in January 1998.
Tamoxifen was discontinued in July 1999 at the
patient’s own request. In December 1999, she presented
with a number of fine nodules and a hard nodule
in her right axilla, which led to the clinical
conclusion of “clearly showing evidence of local recurrence
of breast cancer.” Tamoxifen was reintroduced.
In January 2000, liver ultrasound showed no evidence
of liver metastasis, and the same was shown in another
liver ultrasound in September 2000. In August 2000, it
was noted that the skin nodules, which had disappeared,
had not recurred. Tests showed that the patient
was postmenopausal, and her hormone treatment was
changed to letrozole.
To date, concurrent examinations
have shown no recurrence of her disease.
Integr Cancer Ther 2007; 6; 80
|
Remember we are NOT Doctors and have NO medical training.
This site is like an Encylopedia - there are many pages, many links on many topics.
Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM. |
|